Dendritic cell vaccination and immune monitoring

被引：0
作者：
E. H. J. G. Aarntzen
C. G. Figdor
G. J. Adema
C. J. A. Punt
I. J. M. de Vries
机构：
[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology
[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato
[4] Radboud University Nijmegen Medical Centre,Oncology
[5] Nijmegen Centre for Molecular Life Sciences,undefined
[6] Radboud University Nijmegen Medical Centre,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.
引用
收藏
页码：1559 / 1568
页数：9
相关论文
共 50 条
  • [21] Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy
    Berlyn, KA
    Ponniah, S
    Stass, SA
    Malone, JG
    Hamlin-Green, G
    Lim, JK
    Cottler-Fox, M
    Tricot, G
    Alexander, RB
    Mann, DL
    Malone, RW
    JOURNAL OF BIOTECHNOLOGY, 1999, 73 (2-3) : 155 - 179
  • [22] Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination
    Liu, Gentao
    Black, Keith L.
    Yu, John S.
    EXPERT REVIEW OF VACCINES, 2006, 5 (02) : 233 - 247
  • [23] Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
    Datsi, Angeliki
    Sorg, Ruediger V.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [24] Dendritic cell-based vaccination against opportunistic fungi
    Bozza, S
    Montagnoli, C
    Gaziano, R
    Rossi, G
    Nkwanyuo, G
    Bellocchio, S
    Romani, L
    VACCINE, 2004, 22 (07) : 857 - 864
  • [25] Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
    Houtenbos, Ilse
    Westers, Theresia M.
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    IMMUNOBIOLOGY, 2006, 211 (6-8) : 677 - 685
  • [26] Ex vivo pulsed dendritic cell vaccination against cancer
    Yang-zhuo Gu
    Xing Zhao
    Xiang-rong Song
    Acta Pharmacologica Sinica, 2020, 41 : 959 - 969
  • [27] Leukaemic dendritic cell vaccination for patients with acute myeloid leukaemia
    Houtenbos, I.
    Westers, T. M.
    Ossenkoppele, G. J.
    de Loosdrecht, A. A. van
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (04) : 445 - 446
  • [28] Empowering dendritic cell cancer vaccination: the role of combinatorial strategies
    Galati, Domenico
    Zanotta, Serena
    CYTOTHERAPY, 2018, 20 (11) : 1309 - 1323
  • [29] Current status of dendritic cell-based-tumor vaccination
    Dannull, J
    Cerny, T
    Ackermann, DK
    Groettrup, M
    ONKOLOGIE, 2000, 23 (06): : 544 - 551
  • [30] Medullary thyroid carcinoma:: Autologous tumor cell lines for dendritic cell vaccination
    Pfragner, R
    Skofitsch, G
    Höger, H
    Jech, M
    Rinner, B
    Siegl, V
    Niederle, B
    Gnant, M
    Friedl, J
    Stift, A
    ANTICANCER RESEARCH, 2005, 25 (6B) : 4225 - 4230
12345